NASDAQ: HOWL
Werewolf Therapeutics, Inc.
Healthcare · Biotechnology
After hours: $0.37(-1.99%) · as of 7:41 PM ET
Market Cap
$18.56M
52w High
$2.38
52w Low
$0.27
P/E
-0.52
Volume
452.17K
Outstanding Shares
48.60M
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock fell 68.18% over the last year. Free cash flow grew 50.54% over the trailing twelve months.
What the market seems to be pricing
Visible fundamentals weakened far less than the stock price. The market appears to be discounting durability, risk, or trust rather than just the latest reported numbers.
What would invalidate this read
This read changes if operating margin (currently -121.78%) continues to decline, or if revenue growth turns negative. The bull case requires the business to hold its current trajectory.
Company profile
Werewolf Therapeutics, Inc. is a biopharmaceutical firm dedicated to developing novel therapies that activate the body's immune system to combat cancer.
Valuation
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Analyst consensus
8
Buy
1
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Nov 3, 2026
Q4 FY26 · EPS est -$0.22 · Revenue est $18.31M
View